Reporting ADR
Please report ALL suspected Adverse Drug Reactions (ADRs), including those to drugs used for COVID-19 treatment, to the National Centre for Adverse Drug Reactions Monitoring.
Information
COVID-19 information.
NPRA's guidance issued during the COVID-19 pandemic - vaccine FAQs, circulars and directives, lot release, AEFI reporting and inspection notices.
COVID-19
Guidance and reference.
FAQ COVID-19 Vaccine
Frequently asked questions about the COVID-19 vaccine.
EnterFAQ: Hand Sanitizers
Cosmetics Section's compilation of frequently asked questions regarding hand sanitizers.
EnterCircular and Directive
Circular and directive on the COVID-19 pandemic.
EnterPress Releases on AEFIs of COVID-19 Vaccines
Press releases on adverse events following immunisation (AEFI) for COVID-19 vaccines.
EnterOfficial Notice for Site Inspections
Official notice for temporary suspension for inspection in and out of Malaysia for GMP, GDP, GCP and GLP and BE Research Centers.
EnterVoluntary Registration of Surface Disinfectant
Guideline for the registration of surface disinfectant.
EnterLot Release for COVID-19 Vaccines
Lot release certificates issued for COVID-19 vaccines supplied in Malaysia.
EnterSummary Reports on AEFIs of COVID-19 Vaccines
Summary reports on AEFIs of COVID-19 vaccines.
EnterFAQ: GMP and GDP Inspections
Frequently asked questions on Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) inspections by the National Pharmaceutical Regulatory Agency (NPRA) during the COVID-19 pandemic.
EnterReport and follow up
Reporting and official updates.
Ministry of Health COVID-19 site
The Ministry of Health's official COVID-19 site, for case numbers, public health advice and national guidance.